Daily Hong Kong Stock Market News Express (Wednesday, February 26)

1. Shimao Group (00813.HK) The Hong Kong Stock Exchange announced that the company is pleased to announce that with the consent of both parties, the High Court has ordered the withdrawal of the petition against the company. 2. Baidu Group (09888.HK): Entered into an agreement with JOYY Inc. and acquired the Chinese mainland video entertainment live broadcast business (ie YY.com) previously owned by JOYY. Baidu has paid a total purchase price of approximately 2.10 billion US dollars. 3. Stone Pharmaceutical Group (01093.HK): It is expected that the net profit in 2024 will decrease by about 26% year-on-year. Mainly due to the price of the two main products of Jinyouli and Domesso, which were reduced by about 58% and 23% respectively in the centralized procurement of drugs in the Beijing-Tianjin-Hebei "3 + N" alliance. 4. China Everbright Water (01857.HK): Revenue in 2024 was about HK $6.852 billion, a slight increase of 2% year-on-year; Net profit was about HK $1.02 billion, a decrease of 14% year-on-year. 5. Budweiser Asia Pacific (01876.HK) announced the results of 2024. The profit attributable to equity holders was US $726 million, a decrease of 14.79% year-on-year, and the final dividend was 5.66 cents per share. 6. China Literature Limited (00772.HK) issued a warning, and it is expected that the annual net loss will be about 150 million yuan to 250 million yuan, which is a year-on-year profit and loss. 7. ASMPT (00522.HK) announced the results of 2024, and the profit attributable to company holders was HK $345 million, a year-on-year decrease of 51.74%. 8. Hansen Pharmaceuticals (03692.HK): HS-20093 for self-developed B7-H3 targeting antibody-drug conjugate (ADC) injection was approved by the State Drug Administration of China (NMPA) for inclusion in breakthrough therapeutic drugs.